PSMA-RGS identified 32 positive stations (16 confirmed as PCa at final pathology) and 41 negative stations (36 without PCa), yielding in vivo sensitivity, specificity, PPV, and NPV of 76%, 69%, 50%, and 88%, respectively. Here, FOLH1 is linked to posterior cortical atrophy.